Related Experiment Video
Updated: May 16, 2026

Improving Reproducibility to Meet Minimal Information for Studies of Extracellular Vesicles 2018 Guidelines in Nanoparticle Tracking Analysis
Published on: November 17, 2021
The Consolidated Standards of Reporting Trials Statement-2025: New epoch for improving the transparency of randomized
Jennee Moirangthem1, Manali Deshpande1, Anant Patil1
1Department of Pharmacology, Dr. D. Y. Patil Medical College, Navi Mumbai, Maharashtra, India.
Abstract:
Randomized controlled trials (RCTs) are considered gold standard study designs. With increasing knowledge and experience, the requirements for designing, conduct and reporting of RCTs is becoming more demanding. The Consolidated Standards of Reporting Trials (CONSORT) has been recommended as reporting guideline for the RCTs. After its first publication in 1996, there have been updates in 2001 and 2010. After almost 15 years of last update, recently revised CONSORT-2025 guideline has been published. Interestingly, the Standard Protocol Items: Recommendations for Interventional Trials guideline first published in 2013 has also undergone revision. The wording of these two guidelines has been harmonized. In this article, we have discussed important updates in the CONSORT 2025 checklist.
Related Concept Videos
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Standards of Care II
Blinding
Standards of Care I
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
